Active Studies
Manage your clinical trial protocols and data
Active Studies
2
All in Progress
Total Forms
31
22 + 9
Total Visits
22
15 + 7
Subjects
2
Both Active
Audit Events
152
110 + 42
Active
Phase III
Osimertinib ± Chemotherapy in EGFR-Mutated NSCLC
FLAURA2 — Advanced non-small cell lung cancer study evaluating osimertinib with or without chemotherapy in EGFR-mutated patients.
22 Forms
15 Visits
71 Fields
1 Subject
Data Completion68%
Active
Phase II
PLANETTE Study
Multicenter phase II study evaluating treatment response and tolerability in advanced solid tumors with platinum-based regimens.
9 Forms
7 Visits
33 Fields
1 Subject
Data Completion54%
Recent Audit Activity
| Time | Study | Action | Table | User |
|---|---|---|---|---|
| 2025-01-15 14:32 | Osimertinib | INSERT | form_data | system |
| 2025-01-15 14:30 | Osimertinib | UPDATE | subjects | system |
| 2025-01-14 09:15 | PLANETTE | INSERT | visit_data | system |
| 2025-01-13 16:44 | Osimertinib | INSERT | subjects | system |
| 2025-01-12 11:20 | PLANETTE | INSERT | form_data | system |